The CEO of Apogee Therapeutics reported selling 20,000 shares of the company for approximately $1.50 million on March 11, 2026. This disposition represented 1.71% of Henderson's direct holdings at the ...

Apogee’s first quarter results were met with a positive market response, reflecting the company’s ability to navigate ...

Apogee Enterprises (NASDAQ:APOG) reported fiscal 2026 fourth-quarter results that management said came in ahead of internal ...

Perceptive Advisors increased its Apogee Therapeutics position by 978,662 shares; the estimated trade value was $61.64 million (based on quarterly average prices). Meanwhile, the quarter-end position ...

One takeaway from the ongoing biotech IPO drought is that companies should have at least some clinical data to persuade investors to buy in. Apogee Therapeutics has no human data. In fact, the young ...

The iconic Apogee Entertainment is back with fresh announcements for four of their indie titles, with announcements across ...

Apogee Therapeutics Inc. (NASDAQ:APGE) stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday. This substantial increase in stock price follows the release of ...

Apogee Enterprises, Inc. (NASDAQ:APOG) shares are trading higher after the company reported second-quarter sales of $342.4 million, beating the consensus estimate of $335.3 million. Revenue fell 3.2% ...

Q4 fiscal 2026. Management view "I'm pleased to share that our results for the quarter were ahead of our expectations on both the ...

The new Apogee Boom audio interface if designed for musicians and live streamers who want pro-quality audio at an entry level price. Apogee Electronics has been making digital audio recording ...